Humans Male Network Meta-Analysis *Prostatic Hyperplasia/surgery Quality of Life Randomized Controlled Trials as Topic *Transurethral Resection of Prostate Treatment Outcome *benign prostatic hyperplasia *network meta-analysis *prostate volume *surgical treatment conflicts of interest with respect to the research authorship and/or publication of this article.

Benign prostatic enlargement Benign prostatic hyperplasia Lower urinary tract symptoms Minimally invasive surgical therapies Prostatic urethral lift Rezum Temporary implantable nitinol device UroLift Water vapor thermal therapy iTind

Anticoagulant therapy benign Prostatic Hyperplasia

Aged Humans Lasers Solid-State Male Middle Aged Postoperative Complications/etiology Prostatic Hyperplasia Quality of Life Transurethral Resection of Prostate Treatment Outcome Volatilization Greenlight photoselective vaporization Holmium laser technologies Laser therapy Meta-analysis Prostate Prostatic hyperplasia

Anticoagulants Humans Male Platelet Aggregation Inhibitors Postoperative Hemorrhage/chemically induced Prostatic Hyperplasia *Transurethral Resection of Prostate

*Bipolar Disorder China Humans Male Prostatectomy *Prostatic Hyperplasia Quality of Life *Transurethral Resection of Prostate Treatment Outcome Benign prostatic hyperplasia High-risk and senior patients Meta-analysis Systematic review Transurethral bipolar plasmakinetic prostatectomy

Thulium laser vaporesection of prostate bipolar transurethral resection of prostate benign prostate hyperplasia meta-analysis

Bph Srd5a2 polymorphism risk susceptibility

*Alleles Ethnicity/genetics *Genetic Association Studies *Genetic Predisposition to Disease Genotype Humans Male Odds Ratio *Polymorphism Single Nucleotide Prostate-Specific Antigen/*genetics Prostatic Hyperplasia/*genetics Publication Bias Risk Factors Bph Psa meta-analysis polymorphism

Surgical Treatments Benign Prostatic Hyperplasia Male Erectile Function Meta-Analysis

Lasers benign prostatic hyperplasia meta-analysis

Humans *Urinary Bladder/pathology Cystectomy/methods Prognosis Prospective Studies Neoplasm Recurrence Local/pathology *Urinary Bladder Neoplasms/pathology Biomarkers biomarker neutrophil-to-lymphocyte ratio prognostic factor radical cystectomy recurrence urothelial carcinoma

Humans *Urinary Bladder Neoplasms/surgery/pathology Lasers Urethra/surgery Treatment Outcome Length of Stay 2-micron laser bladder cancer meta-analysis randomized controlled trials trans-urethral resection of bladder tumor

膀胱热灌注化疗 非肌层浸润性膀胱癌 热疗 经尿道膀胱肿瘤电切术

Bladder cancer Pd-1 Pd-l1 atezolizumab avelumab biomarkers durvalumab immunotherapy nivolumab pembrolizumab Urogen licenses/patents: University of Colorado research support: Medivation/Astellas stockholder in: Aurora Oncology PrecisionProfile other: IOS Press (editorial responsibilities compensated).The other authors report no conflicts of interest.

Biomarkers Tumor *Cystoscopy *Cytodiagnosis Early Detection of Cancer Humans Prospective Studies Reproducibility of Results Retrospective Studies Sensitivity and Specificity Urinary Bladder Neoplasms/complications/*diagnosis/pathology Urinary Bladder Neurogenic/*complications (MeSH): neurogenic bladder bladder cancer cystoscopy screening urinary cytology

Age Factors Cystoscopy/*methods Cytodiagnosis Hematuria/*complications/*diagnosis Humans Predictive Value of Tests Sex Factors Smoking Time Factors Urinary Bladder Neoplasms/*complications/diagnosis/urine bladder cancer diagnosis haematuria timeliness urinary bladder neoplasm

Asian People/genetics Female Humans Male Microtubule-Associated Proteins/*genetics *Polymorphism Single Nucleotide Urinary Bladder Neoplasms/ethnology/*genetics/pathology White People/genetics

Cystectomy/*methods Humans Prognosis *Quality of Life Urinary Bladder Neoplasms/*surgery Bladder cancer Continent urinary diversion Incontinent urinary diversion Quality of life Radical cystectomy